Continuing Education Information
The cost of CME and CEU credits is included in the registration fee.
CME and CEUs are reported by each attendee seeking credit at the conclusion of the meeting via the online Self-Reporting system. Instructions for utilizing the computers in the on-site Cyber Cafe or the attendees own computer will be provided in the registration materials handed out on-site.
Continuing Medical Education (CME) Credit
The American College of Medical Genetics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Medical Genetics and Genomics designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity (Maximum 19.5 AMA PRA Category 1 Credits™ if you are not attending a Short Course).
CME certificate is accepted by the ABMGG for certification.
Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized American College of Medical Genetics and Genomics to offer up to 3.2 CEUs or 32.5 Category 1 contact hours for the event 2017 ACMG Annual Clinical Genetics Meeting. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
(Maximum 2.8 CEUs or 28 Category 1 contact hours if you are not attending a Short Course)
Genetic counselors MUST claim credit hours online by May 26, 2017. CEU certificates are sent from the National Society of Genetic Counseling. They will be emailed by NSGC approximately 2 months after ACMG sends the report to NSGC of those who have claimed CEUs.
P.A.C.E. CEU's – Laboratory Directors and Laboratory Personnel
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program. The American College of Medical Genetics and Genomics designates the 2017 ACMG Annual Clinical Genetics Meeting for a maximum 24 contact hours. ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider #50-11878. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.® Program as CE Provider # 0001 (19.5 P.A.C.E. Credit if you are not attending a Short Course).
Content Validation and Fair Balance
1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
a) All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.
2. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
3. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.
Off-label Uses of Products
When an off-label use of a product, or an investigational use not yet approved for any purpose, is discussed during an educational activity, the accredited sponsor shall require the speaker to disclose that the product is not labeled for the use under discussion, or that the product is still investigational. Discussions of such uses shall focus on those uses that have been subject of objective investigation.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) and the policy of the American College of Medical Genetics and Genomics (ACMG), speakers and moderators presenting in sessions that offer CME and CEU credit must disclose, prior to the start of their presentations, the existence of any relevant financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s), including diagnostic laboratories to be discussed during their presentation. These disclosures are included in the Disclosure section of this program guide.
Speakers with disclosures are required to provide a slide that states any relevant financial relationships (or lack thereof), and to state these to the audience at the start of their presentation. All disclosures have been peer reviewed by the ACMG Program/Education subcommittee.
Diagnostic and Testing Labs and Commercial Interest
ACMG CME activities adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. The ACCME has defined under its conflict of interest definition the types of industry interests that must be excluded from CME content delivery. This largely applies to manufacturers of pharmaceuticals and devices. Diagnostic laboratories, whether not-for-profit or for-profit, that are not owned by device manufacturers are exempted from this CME requirement. However, they are still expected to be fair and balanced in their presentations
HIPAA Compliance by Speakers and Presenters
The ACMG supports medical information privacy. While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the ACMG HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available upon request.
ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or test, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.
Questions regarding CE credit should be directed to firstname.lastname@example.org.